Gene Query: FKBP15

Dataset Description Geneva Score
The effect of Foxc1 deficiency on undifferentiated and differentiated human primary keratinocytes 37.47
Identification of differential expressed genes of JQ1 or JQ1+Bortezomib in colorectal cancer cells 28.98
Whole transcriptome sequencing identifies increased CXCR2 expression in PNH granulocytes 24.39
Transcription factor p63 bookmarks genomic loci in epithelial cells and regulates a subset of target genes during epidermal differentiation through dynamic enhancers 19.65
Transcription factor p63 bookmarks genomic loci in epithelial cells and regulates a subset of target genes during epidermal differentiation through dynamic enhancers (RNA-Seq) 19.65
Global transcriptional profiling changes upon knockdown of G9a in human non-small cell lung cancer cells 19.36
IgG immunocomplexes sensitize human monocytes for inflammatory hyperactivity via transcriptomic and epigenetic reprogramming in Rheumatoid Arthritis 19.16
Whole-transcriptome profilings between a pair of HCA7-derived KRAS-wildtype cetuximab sensitive and resistant colon cancer cells from 3D culture 19.08
Genome-wide expression profiling of an in vitro model for studying esophageal epithelial differentiation 18.83
BAF controls genome accessibility 18.54
RNA sequencing of erythroid and granulomonocytic colonies differentiated from transduced bone marrow CD34+ cells expressing U2AF1 S34F mutation, U2AF1 wild-type or empty vector control 16.89
Forkhead domain mutations in FOXA1 drive prostate cancer cell progression 16.45
RNA-seq in LNCaP cell line overexpressing WT or mutant FOXA1 16.45
Utilizing single-cell variations to reveal environment-dependent tuning of network connectivity in human macrophages (RNA-Seq, CAGE and ChIP-Seq) 16.01
Utilizing single-cell variations to reveal environment-dependent tuning of network connectivity in human macrophages 16.01
Genome-wide analysis of STAT3 in diffuse large B-cell lymphoma 15.57
Widespread intronic polyadenylation diversifies immune cell transcriptomes 14.71
Bacterial Infection Remodels the DNA Methylation Landscape of Human Dendritic Cells (wtRNA-Seq) 14.57
CircRNAome diversity in human mature B-cells, T-cells and monocytes 14.35
RNA-seq analysis to identify the genes regulated by p53-SET interplay 13.99
JAK/STAT inhibition in macrophages promotes therapeutic resistance by inducing expression of protumorigenic factors 13.87
Identification of monocyte-like precursors of granulocytes as a mechanism for accumulation of PMN-MDSC in cancer 13.21
Expression profile and potential functions of circulating long noncoding RNAs in acute ischemic stroke in the Southern Chinese Han population 12.62
BET bromodomain proteins function as master transcription elongation factors independent of CDK9 recruitment [NET-seq] 12.35
Transcriptomics of human macrophages upon infection with Legionella pneumophila and two isogenic mutants, LamA and AnkH using RNA-seq 12.31
Immune-restricted epigenetic reader SP140 maintains macrophage identity and activation states critical to intestinal homeostasis [RNA-seq] 12.26
Immune-restricted epigenetic reader SP140 maintains macrophage identity and activation states critical to intestinal homeostasis 12.26
A transcriptional regulatory network connects mitochondrial biogenesis and metabolic shift with stem cell commitment to hepatic differentiation 11.8
Transcriptional changes in pancreatic cancer cells associated with gemcitabine resistance 11.48
4sU-seq of HFF exposed to salt and heat stress 11.43
Catalogue of differentially expressed long non-coding RNAs following activation of human and mouse innate immunity 11.38
TLR2 dimerization blockade allows generation of homeostatic intestinal macrophages under acute colitis challenge 11.37
H3B-8800, a novel oral splicing modulator, induces lethality in spliceosome mutant cancers [Nalm-6] 11.06
Generation and functional characterization of MDSC-like cells 11.04
RNA-seq of stable and unstable section of human atherosclerotic plaques 10.66
Nickel induced transcriptional changes persist post exposure through epigenetic reprograming (RNA-seq dataset) 10.31
Gene activation precedes DNA demethylation in response to infection in human dendritic cells 10.05
Gene activation precedes DNA demethylation in response to infection in human dendritic cells 10.05
Human blood CD1c⁺ dendritic cells encompass CD5-high and CD5-low subsets that differ significantly in phenotype, gene expression and functions 9.87
Hypoxic transcriptome of SQ20B human head and neck cancer cells 9.68
Characterization of macrophage - cancer cell crosstalk in estrogen receptor positive and triple-negative breast cancer 9.63
Cohesin and CTCF Differentially Affect the Chromatin Architecture and Gene Expression in Human Cells 9.52
Human cells contain natural double-stranded RNAs with potential regulatory capacity 9.51
Expression changes in melanoma cell lines under BRAFi treatment timepoints [RNA-Seq.CellLine.batch3] 9.47
R430: A potent inbibitor of DNA and RNA viruses 9.42
RNA-Seq Samples of siTFE3 in 8988T PDA Cell Line to Investigate Transcriptional Control of the Autophagy-Lysosome System 9.27
Function of HNRNPC in breast cancer cells by controlling the dsRNA-induced interferon response 9.12
Global transcriptional profiling changes upon knockout of USP22 in human Non-small cell lung cancer cells 8.98
Dynamic and stable enhancer-promoter contacts regulate terminal differentiation [RNA-Seq] 8.97
Dynamic and stable enhancer-promoter contacts regulate terminal differentiation 8.97
Super-Enhancers Promote Transcriptional Dysregulation in Nasopharyngeal Carcinoma 8.78
Super-Enhancers Promote Transcriptional Dysregulation in Nasopharyngeal Carcinoma [RNA-seq] 8.78
Absence of NKG2D ligands defines human leukaemia stem cells and mediates their immune evasion 8.6
The evolution of N6-methyladenosine in primates 8.52
p63 controls the enhancer landscape during keratinocyte differentiation 8.46
IFN-g Regulates mTORC1, Cellular Metabolism and mRNA Translation to Potentiate Inflammatory Macrophage Activation 8.46
IFN-g Regulates mTORC1, Cellular Metabolism and mRNA Translation to Potentiate Inflammatory Macrophage Activation [RNA-Seq] 8.46
Expression analysis of primary human monocytes stimulated with an anti-TLR10 mAb (5C2C5) 8.32
EZHIP constrains Polycomb Repressive Complex 2 activity in germ cells (RNA-Seq) 8.04
EZHIP constrains Polycomb Repressive Complex 2 activity in germ cells 8.04
A Surveillance System of Active Enhancers by a RACK7-histone Demethylase Complex (RNA-Seq I) 7.98
RNA-seq in acute myeloid leukemia (AML) cells with and without knockdown of METTL14 7.98
Transcriptome analysis of A549 cells expressing a SUMOylation-deficient TRIM28 mutant in the context of influenza A virus infection 7.97
Endothelial TGFb signaling drives vascular inflammation and atherosclerosis 7.88
Endothelial TGFb signaling drives vascular inflammation and atherosclerosis [bulk RNA-Seq] 7.88
Ribosome queuing enables non-AUG translation to be resistant to multiple protein synthesis inhibitors 7.82
Co-expression of CD163 and CD141 Identifies Human Circulating IL-10-Producing Dendritic Cells (DC-10) [RNA-seq] 7.79
Co-expression of CD163 and CD141 Identifies Human Circulating IL-10-Producing Dendritic Cells (DC-10) 7.79
RNA-Seq from human ILC transitional populations 7.77
Expression profiling of ILC transitional populations and Aiolos accessability and H3K27ac histone modifications in transfected MNK3 cells 7.77
DAOY-Notch1/Notch2 knockout: transcriptome comparison 7.66
Aging of hematopoietic stem cells is driven by regional specialization of marrow macrophages 7.65
Human CD11b+ macrophages - Aging of hematopoietic stem cells is driven by regional specialization of marrow macrophages 7.65
Global gene expression profile of human peripheral blood-derived endothelial colony-forming cells is similar to coronary artery and umbilical vein endothelial cells 7.6
Rational targeting of RNA structure in SMN2 transcripts reverses Spinal Muscular Atrophy molecular phenotypes 7.59
Selectively targeting bromodomain and extraterminal proteins for degradation as a novel anti-glioblastoma strategy [RNA-seq] 7.47
Combined cistrome and transcriptome analysis of SKI in AML cells identifies SKI as a co-repressor for RUNX1 7.45
Transcriptome analysis of SKI knock-out in HL60 cells 7.45
Sorted MDMs with RFP+GFP+ or RFP+GFP- Mtb 7.43
Global transcriptional profiling changes upon knockdown of LKB1 in human glioblastoma cell lines 7.38
Integrin signaling regulates YAP/TAZ to control skin homeostasis 7.3
Effect of ROQUIN2(Y691F) expression on mRNA levels upon BCR stimulation 7.28
The role of antigen presenting cells in the induction of HIV-1 latency in resting CD4+ T-cells 7.27
Analysis of the polyA+ RNA of LPS-treated human CD14+ monocytes 7.22
RNA-Seq analysis of primary human keratinocytes exposed to Cannabidiol 7.18
Zika virus antagonizes interferon response in patients and disrupts RIG-I-MAVS interaction through its CARD-TM domains 7.16
Metabolic reprogramming of Kaposi’s sarcoma associated herpes virus infected B-cells in hypoxia 7.16
Be1 and Be2 B cells are transcriptionally distinct 7.15
ZFR coordinates crosstalk between RNA decay and transcription in innate immunity 7.14
The effects of U1 snRNA mutation in chronic lymphocytic leukemia cell lines 7.05
Transcriptomic analysis of senescent cells upon PTBP1 knockdown. 7.02
Quantitative mass spectrometry-based proteomics reveals the dynamic protein landscape during initiation of human Th17 cell polarization 6.86
Transcriptional profile of human STAT1-/- fibroblasts expressing IFI6 or empty control vector 6.84
Extensive remodeling of DC function by rapid maturation-induced epigenetic gene silencing 6.76
Extensive remodeling of DC function by rapid maturation-induced epigenetic gene silencing [RNA-Seq] 6.76
The Jumonji-domain histone demethylase inhibitor JIB-04 deregulates oncogenic programs and increases DNA damage in Ewing Sarcoma, resulting in impaired cell proliferation and survival, and reduced tumor growth 6.74
Single-cell epigenomics maps the continuous regulatory landscape of human hematopoietic differentiation 6.73
Single-cell epigenomics maps the continuous regulatory landscape of human hematopoietic differentiation [bulk RNA-Seq] 6.73
Single cell RNA sequencing reveals microglia-like cells in cerebrospinal fluid  during virologically suppressed HIV 6.7
Canonical poly(A) polymerase activity promotes the decay of a wide variety of mammalian nuclear RNAs 6.67
Effect of 48h treatment with 100nM GSK2879552 on T-ALL cell lines LOUCY and PEER 6.65
Comparative genome-wide analysis of human BM IL3Rα-high precursors show a more MΦ-, DC- and OC committed gene expression profile, as compared to IL3Rα-low precursors 6.65
Bacterial Infection Remodels the DNA Methylation Landscape of Human Dendritic Cells (mRNA-Seq) 6.65
Nucleotide stress induction of HEXIM1 suppresses melanoma by modulating cancer cell-specific gene transcription [RNA-Seq2] 6.64
T47D RNA-seq and ChrRNA-seq data 6.56
Arginine citrullination at the C-terminal domain controls RNA Polymerase II transcription 6.56
MYC dependent mRNA translation shapes gene expression and cell biology 6.54
Trisomy of a ‘Down syndrome critical region’ globally amplifies transcription via HMGN1 overexpression 6.52
Therapeutic targeting of KDM1A/LSD1 in Ewing sarcoma engages the ER-stress response II 6.51
RNAseq to determine gene expression changes following depletion of SETDB1 in THP-1 AML Cells 6.46
RNA-seq analysis of control and ZC3H18-depleted ovarian cancer cells 6.45
H3K27Ac in MCF7 Y537S ER mutant cells and RNAseq with and without treatment with THZ1 6.4
Immunological Imbalance in Fibrodysplasia Ossificans Progressiva Revealed by PBMC Transcriptome Analysis 6.36
MLL-AF4 binds directly to a BCL-2 specific enhancer and impacts H3K27 acetylation 6.34
The regulartory role of ZCCHC24 in splicing machinery 6.34
AQP5-Expressing Cells Serve as Stem Cells and Cancer Origins in the Distal Stomach 6.33
Intron retention induced by microsatellite expansions as a disease biomarker. 6.32
RNAseq to determine whether bidirectional transcription occurs over transposable elements following depletion of SETDB1 in THP-1 AML Cells 6.3
Sequencing-based analyses characterize a tumor suppressive role of mir-1271 repressed by DNA hypermethylation in gastric cancer 6.26
Seletive inhibition of CDK9 in DLBCL cell lines 6.25
Aging Human Hematopoietic Stem Cells Manifest Profound Epigenetic Reprogramming of Enhancers That May Predispose to Leukemia (RNA-seq of KLF6 KO) 6.19
Epigenetic programming during monocyte to macrophage differentiation and trained innate immunity 6.15
Global analysis of ZNF217 chromatin occupancy in the breast cancer cell genome reveals an association with Eralpha 5.96
ATF4 inhibition by p62 represses stromal metabolic reprogramming and tumorigenesis II 5.95
Global analysis of pre-mRNA subcellular localization upon splicing inhibition by spliceostatin A 5.94
Oncogenic Notch promotes long-range regulatory interactions within hyperconnected 3D cliques [MB157_RNA-seq] 5.92
A NIK-SIX signaling axis controls inflammation by targeted silencing of noncanonical NF-κB 5.92
Alternative splicing of differentiated myeloid cell transcripts after infection by Anaplasma phagocytophilum impacts a selective group of cellular programs 5.91
RNAseq Study in CC-671 Treated Cal-51 Cells 5.84
Nuclear Parkin Regulates Transcriptional Response during Hypoxia 5.8
Biological effect of chronic mistranslation in mammalian cells 5.8
RNA-sequencing of human tendon after injury 5.75
The translation termination factor GSPT1 is a phenotypically relevant off-target of heterobifunctional phthalimide degraders 5.73
Messenger RNA profile analysis deciphers new Esrrb responsive genes in prostate cancer cells 5.7
ARID2 promotes clear cell renal cell carcinoma in the absence of functional PBRM1 5.67
ARID2 promotes clear cell renal cell carcinoma in the absence of functional PBRM1 [RNA-seq] 5.67
Short and Long RNA sequencing of human mature erythrocytes 5.67
Diffuse Large B Cell Lymphoma cell line with Acquired Resistance to PI3Kδ Inhibitor Idelalisib 5.66
ZIKV infection of monocytes activates inflammasome pathways 5.64
Wide-scale analysis of alternative polyadenylation (APA) associated with proliferation and transformation using 3'-Seq 5.63
oxLDL exposed trained monocytes 5.61
Transcriptomes of oxLDL exposed trained monocytes 5.61
RNA sequencing of mechanically strained NHEKs and control NHEKs 5.59
hMTR4 plays a central role in creating balanced nuclear RNA pools for degradation and export II 5.57
Transcriptional change of THP-1 after HSV-1UL37WT or HSV-1UL37C819S 5.54
Landscape and variation of RNA secondary structure across the human transcriptome 5.52
Waterpipe Smoking Induces Epigenetic Changes in the Small Airway Epithelium 5.48
Waterpipe Smoking Induces Epigenetic Changes in the Small Airway Epithelium [RNA-Seq] 5.48
Genome-wide maps in MCF-7 cells with six2 or CYP4Z1 3'UTR or CYP4Z2P 3'UTR overexpression or not 5.46
Generation of mature lung alveolar epithelial cells from human pluripotent stem cells 5.45
Poly(A)-ClickSeq resolves CF25-mediated alternative poly-adenylation, HeLa 5.42
Bacterial Infection Remodels the DNA Methylation Landscape of Human Dendritic Cells 5.34
RNA-seq data corresponding to: AZD4573 is a highly selective CDK9 inhibitor that suppresses Mcl-1 and induces apoptosis in hematological cancer cells 5.34
Prediction of bacterial infection outcome using single cell RNA-seq analysis of human immune cells [sorted population Bulk RNA-seq] 5.34
IQGAP3 interacts with Rad17 to activate the MRN/ATM/Chk2 signaling and promote radioresistance in lung cancer 5.32
Targeting MTHFD2 in Acute Myeloid Leukemia 5.31
Transcriptome-profiling (RNA-seq) and Ribosome-profiling (Ribo-seq) of BJ cells treated with Nutlin-3a, an MDM2 inhibitor, which induces p53. 5.27
U1 snRNP telescripting regulates size-function stratified human genome 5.27
Genome-wide expression analysis of human hTert immortalized fibroblasts after downregulation of MCM2 5.24
CTCF and CohesinSA-1 Mark Active Promoters and Boundaries of Repressive Chromatin Domains in Primary Human Erythroid Cells [RNA-Seq] 5.22
CTCF and CohesinSA-1 Mark Active Promoters and Boundaries of Repressive Chromatin Domains in Primary Human Erythroid Cells 5.22
Acetyl-CoA carboxylase inhibition regulates microtubule dynamics and intracellular transport in cystic fibrosis epithelial cells 5.22
Dynamics of the human and viral m6A RNA methylomes during HIV-1 infection of T cells 5.21
RNA-sequencing time course of Human Intestinal Epithelial Cells (HIECs) following knockdown of miR-30bcd using complementary locked nucleic acids 5.21
Identification of the networks that regulate human monocytic myeloid-derived suppressor cell differentiation into inflammatory macrophages 5.21
RNAseq of PRMT4KD in human cord blood derived CD34+ cells 5.19
IL-11 neutralising therapies for the treatment of nonalcoholic steatohepatitis 5.17
Human lymph nodes maintain a unique subset of resident memory T cells with high functional potential important for protective immunity and immunotherapies 5.15
RNA-seq in transgenic cells 5.14
THZ1 targeting CDK7 suppresses STAT transcriptional activity and sensitizes T-cell lymphomas to BCL2 inhibitors 5.09
Global transcriptional changes in U87MG glioblastoma cells upon shRNA-mediated TRIM52 knockdown 5.06
Human macrophages exhibit high activity to clear intracellular biovar Microtus strain of Y. pestis 5.04
Transcriptome analysis reveals malignant and hypoxic signature of glioblastoma 5.02
Involvement of Condensin in Cellular Senescence through Gene Regulation and Compartmental Reorganization 4.92
Precise Gene Editing Preserves Hematopoietic Stem Cell Function Following Transient p53-Mediate DNA Damage Response 4.92
RNA-Seq gene profiling comparison from human cDC subsets and pre-cDC subsets 4.91
Systematic Functional Perturbations Uncover a Prognostic Genetic Network Driving Human Breast Cancer 4.89
Systematic Functional Perturbations Uncover a Prognostic Genetic Network Driving Human Breast Cancer [RNA-Seq] 4.89
Transcriptomic analyssis following EHMT1/2 inhibition 4.89
Transcriptomic profiling of normal human cardiac fibroblast treated with halofuginone 4.89
Gene expression changes caused by KRAS in MCF-10A 4.89
SNHG15 is a bifunctional MYC-regulated noncoding locus encoding a lncRNA that promotes cell proliferation, invasion and drug resistance in colorectal cancer by interacting with AIF 4.89
RNA-Seq analysis of breast cancer cells after shikonin treatment 4.86
Global transcriptional changes in the JJN3 myeloma cell line that occur as a result of treatment with 2 pyrrolobenzodiazepine (PBD) monomers 4.86
Transcriptomes of human monocytes after ex vivo exposure to uric acid 4.85
Tumors with TSC mutations are sensitive to CDK7 inhibition through NRF2 and glutathione depletion 4.84
Genome-wide Analysis of Human Constitutive Androstane Receptor (CAR) Transcriptome in Wild-type and CAR-knockout HepaRG cells 4.82
A pooled single-cell genetic screen identifies regulatory barriers in the continuum of the epithelial-to-mesenchymal transition 4.81
Novel Transcriptional Activity and Extensive Allelic Imbalance in the Human MHC Region 4.81
mRNA expression in iPS cells generated by a synthetic self-replicative RNA 4.79
Subcellular RNA fractions of HSV-1 infected primary human fibroblasts 4.79
FMRP-associated MOV10 facilitates and antagonizes miRNA-mediated regulation 4.78
Trans-chromosomal regulation by a novel lincRNA required for adipogenesis that escapes X-chromosome inactivation 4.77
Alarmin S100A11 initiates a chemokine response to the human pathogen Toxoplasma gondii 4.76
The role of TFEB in retinoid induced differentiation of NB4 APL leukemic cells (shTFEB) 4.74
CNOT1 and Transcriptomic Landscape of a HeLa Cell Line 4.74
KANK1 inhibits cell growth by inducing apoptosis though regulating CXXC5 in human malignant peripheral nerve sheath tumors 4.71
A transcriptome dataset revealing the molecular features of breast cancer stem cells 4.7
Transcription elongation factors are in vivo-specific cancer dependencies in glioma 4.63
RNA-seq Profiles in Transcription elongation factors are in vivo-specific cancer dependencies in glioma 4.63
RNA-Seq and ATAC-Seq in SMARCD2 k/d NB4 cells with/without ATRA differentiation 4.6
RNA-Seq in SMARCD2 k/d NB4 cells with/without ATRA differentiation 4.6
Comprehensive RNA-Seq profiling in PBMCs of ALS patients and healthy controls 4.58
RNA-Seq profiling in PBMCs and spinal cord from ALS patients and healthy controls 4.58
Agonistic targeting of TLR1/TLR2 induces p38 MAPK-dependent apoptosis and NfkB-dependent differentiation of AML cells 4.55
ELF4 is a target of miR-124 and promotes neuroblastoma proliferation and undifferentiated state 4.55
The dynamics of cellular response to therapeutic perturbation using multiplexed quantification of the proteome and transcriptome at single-cell resolution 4.55
Identification of renal resident macrophages across species 4.52
Nuclear HNRNPA2B1 HITS-CLIP and RNA-seq 4.51
Identification of PRMT5-dependent genes in ESA+CD24lowCD44+ MCF7 cells 4.51
Transcriptome landscape of human primary monocytes response upon different ligand glucocorticoids 4.51
Efficient derivation of microglia-like cells from human pluripotent stem cells 4.49
Charaterization of genetic alterations and gene expression signatures found in BCR-ABL inhibitor-resistant KCL-22 subpopulations and single clones 4.48
Landscape of human mast cell chromatin: a rich resource for identification of novel mediators and genetic drivers of allergic and inflammatory diseases 4.47
Transcriptomic profiling of human CD34+ derived mast cells [RNA-Seq] 4.47
Functional role of SLIT2 and ROBO1 in trophoblasts 4.44
A quantitative chemotherapy genetic interaction map identifies new factors associated with PARP inhibitor resistance 4.42
RNA-Seq comparative analysis of human neuroblastoma cells before and after their confrontation to the embryonic microenvironment 4.42
Heterogeneous nuclear ribonucleoprotein C1/C2 links transcriptional and splicing actions of 1,25-dihydroxyvitamin D 4.41
The ribonuclease activity of SAMHD1 is required for HIV-1 restriction 4.36
Enhancer divergence and cis-regulatory evolution in the human and chimpanzee neural crest 4.35
CD95L derived si- and shRNAs kill cancer cells through an RNAi mechanism by targeting survival genes [shL3.shR6.RNAseq.lg] 4.34
MeRIP-seq for heat shock in B-cell lymphoma cells 4.31
Effects of Cardiac Glycosides on RNA Expression in Prostate Cancer LNCaP-abl Cells 4.3
Precise Gene Editing Preserves Hematopoietic Stem Cell Function Following Transient p53-Mediate DNA Damage Response [bulk RNA-seq] 4.28
RNA-seq of young and quiescent MRC-5 human fibroblasts 4.27
Identification of alternatively spliced transcripts in brain metastatic derivatives of MDA-MB-231 breast cancer cells in response to RBM47 expression 4.26
The identification of RBM47 binding sites and RBM47-dependent alternative splicing events in brain metastatic breast cancer cells 4.26
DNA methylation state is associated with the formation of loops and links in hematopoietic stem cells 4.26
DNA methylation state is associated with the formation of loops and links in hematopoietic stem cells [RNA-seq] 4.26
Genes significantly down or Up-regulated upon RNF219 knockdown 4.25
UBC9 knockdown in bladder cancer T24 cell lines 4.23
ERK potentiates transactivation and oncogenic function of ERG by phosphorylation induced dissociation of PRC2 complex 4.22
Global gene expression analysis of human monocyte-derived dendritic cells (DCs) treated with HMGN1 (N1) and R848 alone or in combination. 4.22
Interaction with WDR5 recruits MYC to a small cohort of genes required for tumor onset and maintenance 4.21
RNA-seq analysis of human cardiosphere cells with different tubule supportive potential 4.2
Gene expression in GBM with Cav3.2 inhibition 4.17
Widespread Transcription beyond mRNA 3’ Ends Yields Abundant Regulatory RNAs 4.13
Gene expression profile of human multiple myeloma cell line MM.1S after knockdown of KDM6B 4.13
Aging-associated patterns in the expression of human endogenous retroviruses 4.12
Transcriptional profile in human S. haematobium infection 4.1
Genomic expression analysis of K562 cells expressing shRNA targeting lncRNA-IIRX and control cells 4.09
m6A level and isoform characterization sequencing (m6A-LAIC-seq) reveal the census and complexity of the m6A epitranscriptome 4.07
Transcriptional profiling of CD45RO+CD57+CD4+ T cells 4.05
Lyophilized human cells stored at room temperature preserve multiple RNA species at excellent quality for RNA sequencing 4.04
RNA seq comparison between scrambled and shGRP78 cells 4.02
Genome-wide transcriptome profiling of NEDD9-regulated genes using RNA-seq 4.01
Viral infection enhances NK cell activation via Type I dependent pathways and can be utilized to enhance influenza-specific monoclonal antibody therapies 4.01
Long non-coding RNA expression profile associated with malignant progression of oral submucous fibrosis 3.98
mRNA cap methyltransferase, RNMT-RAM, promotes RNA pol II transcription 3.98
Enhanced T cell responses to IL-6 in type 1 diabetes are associated with early clinical disease and increased IL-6 receptor expression 3.97
Self-associated molecular patterns mediate cancer immune evasion by engagement of Siglec receptors 3.97
Genome wide characterization of a STAT1-independent antiviral and immunoregulatory transcriptional program induced by IFNβ and TNFα reveals non-canonical STAT2 and IRF9 pathways 3.93
A Unique Epigenomic Landscape Defines Human Erythropoiesis 3.93
A Unique Epigenomic Landscape Defines Human Erythropoiesis (RNA-seq) 3.93
Developmental origins define epigenomic differences between subcutaneous and visceral adipocytes [RNA-Seq] 3.91
RNA sequencing of human macrophages treated with iron chelator deferiprone (DEF), with and without lipopolysaccharide (LPS) 3.86
K562 polyA RNA-Seq 3.84
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells [BAA] 3.84
Lung adenocarcinoma metastasis is suppressed by the alveolar lineage transcription factors GATA6 and HOPX. 3.83
Loss of 9p21 regulatory hub promotes kidney cancer progression by upregulating HOXB13 3.81
Differential mRNA expression upon 9p21 deletion in HEK TE single-cell derived clones 3.81
REPROGRAMMING IDENTIFIES FUNCTIONALLY DISTINCT STAGES OF CLONAL EVOLUTION IN MYELODYSPLASTIC SYNDROMES 3.79
4sUDRB-seq: measuring transcription elongation and initiation genomewide 3.76
Non-IG Aberrations of FOXP1 in B-Cell Malignancies Lead to an Aberrant Expression of N-Truncated Isoforms of FOXP1 3.75
Musashi-2 attenuates AHR signalling to expand human haematopoietic stem cells 3.72
Replication defective viral products exploit a cellular pro-survival mechanism to establish persistent infections 3.69
Nucleosome dynamics in human colorectal cancer specimens reveal activation of a CNOT3-regulated pathway of embryonic stem cell self-renewal 3.68
Global Transcriptome Analyses of Mammalian Terminal Erythroid Differentiation 3.64
Epigenetic reprogramming of melanoma cells by vitamin C treatment 3.62
RNA-seq analysis of differentiating human erythroblasts 3.6
RNA-sequencing of fibrolamellar carcinoma (FLC) cell line treated with miR-375 mimic 3.58
Polysome profiling RNAseq of cells transfected with an oligonucleotide targeting the ES6S region of the 40S subunit 3.57
RNA-seq reveals abundant circRNA, lncRNA and mRNA in blood exosomes of patients with pancreatic carcinoma 3.56
A genome-wide long noncoding RNA CRISPRi screen identifies PRANCR as a novel regulator of epidermal homeostasis 3.55
RNA-seq of RKO cells with cTAZ KO or putback 3.52
Ro60-knockout cells 3.49
Plasma cell mitochondrial pyruvate import controls the duration of humoral immunity. 3.47
Targeting MYC dependency in ovarian cancer through inhibition of CDK7 and CDK12/13 3.44
Global Mapping of Human RNA-RNA Interactions 3.42
Global transcript structure resolution of high gene density genomes through multi-platform data integration: Illumina RNA-Seq 3.42
Limiting cholesterol biosynthetic flux engages type I IFN signaling in a STING-dependent manner 3.41
Transcriptome analysis of Riociguat and Vehicle control treatment in human hematopoietic stem and progenitor cells 3.4
RNA-Seq of human PDA cell lines transfected with control siRNA or Pdx1 siRNA 3.4
Integrin αvβ3 acting as membrane receptor for thyroid hormones mediates angiogenesis in malignant T cells 3.33
PRDM1 inhibits proliferation of human colon cancer organoids 3.31
RNA-seq analysis of BAP1-depleted uveal melanoma cells 3.28
lncRNA expression analysis in patients with eosinophilic and neutrophilic asthma 3.28
Expression profiling of MCF-7 cells with 10nM treatment of TCDD 3.27
Expression profiling of MCF-7 cells with treatment of TCDD 3.27
Regeneration of the lung alveolus by an evolutionarily conserved epithelial progenitor. 3.25
Regeneration of the lung alveolus by an evolutionarily conserved epithelial progenitor [human RNA-seq] 3.25
Mapping interactions for the TNIP2 hub protein 3.23
Cyclophosphamide (CTX) Enhances Cancer Antibody Immunotherapy in the Resistant Bone Marrow Niche by Modulating Macrophage FcγR Expression 3.21
LIN28A Over-expression RNAseq 3.21
An evolutionary recent IFN-IL-6-CEBP axis is linked to monocyte expansion and tuberculosis severity in humans. 3.19
Disease modelling of core pre-mRNA splicing factor haploinsufficiency 3.18
Transcriptomic profiling of cleavage-resistant RIPK1 induced autoinflammation syndrome patients 3.18
Long noncoding RNA signatures induced by TLR7 and type I IFN signaling in activated human plasmacytoid dendritic cells 3.09
RNA-sequencing of mRNAs from control and CAP-D3 deficient Salmonella infected HT-29 cells 3.09
Development of a selective CDK9 degrader from a multi-targeted CDK inhibitor [RNA-seq] 3.08
Development of a selective CDK9 degrader from a multi-targeted CDK inhibitor 3.08
Pain-driven transcriptome changes in synovium of knee osteoarthritis patients 3.07
AML subtype is a major determinant of the association between prognostic gene expression signatures and their clinical significance. 3.0
Transcriptome wide analysis of classically and alternatively activated macrophages 2.98
FBP2 inhibits sarcoma progression by restraining mitochondrial biogenesis 2.98
Epigenomes and Transcriptomes of human monocytes from Hyper IgD Syndrome (HIDS) patients 2.94
Next-generation sequencing reveals a novel role of lysine-specific demethylase 1 in adhesion of rhabdomyosarcoma cells [RNA-seq] 2.92
Next-generation sequencing reveals a novel role of lysine-specific demethylase 1 in adhesion of rhabdomyosarcoma cells 2.92
Simultaneous profiling of sexually transmitted bacterial pathogens, microbiome, and concordant host response in cervical samples using whole transcriptome sequencing analysis 2.91
Therapy-induced hypoxia contributes to AML drug-resistance through BMX Kinase upregulation 2.87
A novel target of EZH1/2 for treatment of mantle cell lymphoma 2.85
The contribution of adenosine receptor 3-mediated signaling to TLR4-induced responses by human dendritic cells 2.83
A Reproducibility-Based Computational Framework Identifies An Inducible, Enhanced Antiviral Dendritic Cell State In HIV-1 Elite Controllers (scRNA-Seq) 2.81
A monocyte gene expression signature in the early clinical course of Parkinson’s disease 2.72
Loss of CREBBP results in gene expression repression in lymphoma cells 2.71
Loss of CREBBP results in H3K27Ac loss at enhancers and gene expression repression in lymphoma cells 2.71
Transcription control by the ENL YEATS domain in acute leukemia [RNA-seq] 2.71
Transcription control by the ENL YEATS domain in acute leukemia 2.71
Comparative Analysis of the Transcriptome of Latent Autoimmune Diabetes (LADA) Patients from Eastern China 2.69
Defective structural RNA processing in relapsing-remitting multiple sclerosis 2.68
Fibroblasts in cholesteatoma activate osteoclasts. 2.66
Binding to SMN2 pre-mRNA-Protein complex elicits specificity for small molecule splicing modifiers 2.61
Estrogen Receptor Beta Impacts Hormone-Induced Alternative mRNA Splicing in Breast Cancer Cells 2.6
Transcriptome analysis of peripheral blood monocytes 2.59
Determination of a comprehensive alternative splicing regulatory network and the combinatorial regulation by key factors during Epithelial-to-Mesenchymal Transition [ESRP KD] 2.58
The dynamic landscape of coding and non-coding RNAs in the innate immune response to microbial pathogens 2.58
X-Ray induced DNA-Hydroxymethylation changes 2.57
RNA-Seq in neutrophils from Antiphospholipid Syndrome 2.56
Stretch-Enhancers Delineate Disease-Associated Regulatory Nodes in T Cells 2.56
KSRP specifies monocytic and granulocytic differentiation through regulating miR-129 biogenesis and RUNX1 expression 2.56
Prolyl hydroxylation regulates protein degradation, synthesis, and splicing in human induced pluripotent stem cell-derived cardiomyocytes 2.55
Arrayed molecular barcoding identifies TNFSF13 as a positive regulator of acute myeloid leukemia-initiating cells 2.46
Poly(ADP-ribose) polymerase 1 is necessary for coactivating hypoxia-inducible factor-1-dependent gene expression by Epstein-Barr virus latent membrane protein 1 2.44
Transcriptomes of human monocytes and monocyte-derived macrophages with or without glucocorticoid treatment 2.43
Metastasis in triple-negative breast cancer 2.43
Functional and genomic characterization of a xenograft model system for the study of metastasis in triple-negative breast cancer. 2.43
Multiplex Enhancer Interference Reveals Collaborative Control of Gene Regulation by Estrogen Receptor Alpha Bound Enhancers 2.43
Multiplex Enhancer Interference Reveals Collaborative Control of Gene Regulation by Estrogen Receptor Alpha Bound Enhancers [RNA-Seq] 2.43
Survival of pancreatic cancer cells lacking KRAS function 2.4
Transcriptomic changes mediated by β-amyloid in human aortic endothelial cells (HAOEC) 2.38
Trisomy of a ‘Down syndrome critical region’ globally amplifies transcription via HMGN1 overexpression [NALM6 RNA-Seq] 2.34
Transcriptome analysis of CNS leukemia 2.28
RNA-seq analysis of primary patient samples to characterize the CNS leukemia 2.28
Discovering human diabetes-risk gene function with genetics and physiological assays 2.27
A histone H3.3 Lysine 36 Trimethylation Reader Connects Chromatin to Regulated Pre-mRNA Processing 2.24
Global host gene expression changes in KSHV+ PEL cells upon KSHV reactivation 2.22
Transcriptome Analysis of PBMCs in peripheral blood of patients with hepatocellular carcinoma 2.19
Parallel T-cell cloning and deep sequencing of the transcripts of human MAIT cells reveal stable oligoclonal TCRβ repertoire 2.17
Identification of Differentially Expressed Splice Variants by the Proteogenomic Pipeline Splicify 2.16
RNA-seq study reveals unique transcriptome expression in systemic lupus erythematosus patients with distinct autoantibody profile 2.15
Nucleoporin-mediated regulation of cell identity genes 2.15
Identification and mitigation of pervasive off-target activity in CRISPR-Cas9 screens for essential non-coding elements 2.14
RNA-seq of cultured human kidney peritubular microvascular endothelial cells following exposure to cyclosporine A 2.13
Improving fibroblast characterization using single-cell RNA sequencing: an optimized tissue disaggregation and data processing pipeline 2.12
Profiling of lung tumor-infiltrating CD8 T cells according to their expression status of CD39 2.12
Remodeling of Ago2-mRNA interactions upon cellular stress reflects miRNA complementarity and correlates with altered translation rates 2.11
Remodeling of Ago2-mRNA interactions upon cellular stress reflects miRNA complementarity and correlates with altered translation rates (part 4) 2.11
Functional studies of missense TREM2 mutations in human stem cell-derived microglia 2.05
TSLP acts on neutrophils to drive complement-mediated killing of methicillin-resistant Staphylococcus aureus 1.95
Characterization of Human Pegivirus Infection in Liver Transplantation Recipients 1.9
RNA-sequencing transcriptome profiling of normal human keratinocytes differentiation 1.9
Genome Wide Chromatin Mapping of accessibility (ATAC-seq) and H3K27ac histone modifications in CD56bright and CD56dim natural killer cells 1.89
RNA-Seq analysis of cSCC cells followed by siRNA-induced gene knockdown of C1s. 1.89
Activation Dynamics and Immunoglobulin Evolution of Pre-existing and Newly Generated Human Memory B-cell Responses to Influenza Hemagglutinin 1.87
Osmostress induced changes of chromatin architecture and transcription in mammalian cells [RNA-Seq, HiC] 1.86
Osmostress induced changes of chromatin architecture and transcription in mammalian cells 1.86
CD74 role in transcription regulation 1.85
CD74 role in transcription regulation [RNA-seq] 1.85
Functional TRIM24 degraders via conjugation of ineffectual bromodomain and VHL ligands [RNA-seq] 1.83
mRNA profiling reveals determinants of trastuzumab efficiency in HER2-positive breast cancer 1.82
Novel Atherogenic Pathways from the Differential Transcriptiome Analysis of Diabetic Epicardial Adipose Tissue 1.82
Single-cell RNA-seq reveals differentiation of bona fide human pDCs and cDC1s in cultures of cord blood CD34+ progenitors, and a newly identified terminal differentiation step of cDC1s 1.8
Transcription factors and stress response gene alterations in human keratinocytes following Solar Simulated Ultra Violet Radiation 1.77
RNA-sequencing of the human milk fat layer during colostrum, transitional, and mature stages of lactation 1.77
Neutrophils in systemic onset Juvenile Idiopathic Arthritis display sepsis-like features which can be reverted by IL-1 blockade 1.77
HMGA1 and FOXM1 synergistically regulate a common gene network modulating angiogenesis in breast cancer 1.76
Quantitative Analysis of p53 and/or TGFBR2 Knockdown Endothelial Transcriptomes after Irradiation 1.76
MondoA Links Muscle Lipid Accumulation and Insulin Resistance Driven by Nutrient Overload 1.75
Transcriptome profiling in primary human skeletal myotubes with MondoA knockdown 1.75
RNAseq transcriptome analysis of White Blood Cells (WBCs) from individuals with and without trisomy 21 1.75
Transcriptomic Analysis of Endothelial Cells from Fibrovascular Membranes in Proliferative Diabetic Retinopathy 1.73
Identification and characterization of circular RNAs as a new class of putative biomarkers in human blood 1.7
Leucegene: AML sequencing (part 6) 1.69
RNA-seq reveals abundant circRNA, lncRNA and mRNA in blood exosomes of patients with colorectal carcinoma 1.68
PRMT5 Interacts with the BCL6 Oncoprotein and is Required for Germinal Center Formation and Lymphoma Cell Survival 1.67
Effect of drugs on transcriptomic profiles 1.67
Transcriptional changes in lymphoma cells induced by LSD1 depletion 1.67
Histone demethylase LSD1 is required for germinal center formation and BCL6 driven lymphomagenesis 1.67
Isolation and sequencing of AGO-bound RNAs reveals characteristics of stem-loop processing in vivo 1.65
H3K36 mutations promote sarcomagenesis through genome-wide remodeling of H3K36 and H3K27 methylation 1.64
H3K36 mutations promote sarcomagenesis through genome-wide remodeling of H3K36 and H3K27 methylation [RNA_Chondroblastoma_H3K36M_H3WT] 1.64
Oxaliplatin resistance is enhanced by saracatinib via upregulation of ABCG1 and Wnt/β-catenin signaling in hepatocellular carcinoma 1.63
Frailty in middle age is associated with race-specific changes to the transcriptome. 1.62
Chronic Myeloid Leukemia (CML), induced pluripotent stem cell (iPSC)-derived lin-CD34+CD45+ (iCD34) cell population 1.57
RNA Expression Profile of Calcified Bicuspid, Tricuspid and Normal Human Aortic Valves by RNA Sequencing [BAV] 1.55
Defining the Transcriptional Landscape during Cytomegalovirus Latency with Single-Cell RNA Sequencing 1.53
RNA-Seq of SLNCR1 over-expression in the melanoma cell line A375 1.52
CD48-dependent protective autophagy in conventional human T cells promotes restimulation-induced cell death resistance 1.52
Tyrosine-1 of RNAPII CTD controls global termination of gene transcription in mammals 1.51
Aging Human Hematopoietic Stem Cells Manifest Profound Epigenetic Reprogramming of Enhancers That May Predispose to Leukemia (RNA-Seq of HSCe) 1.5
RNA-sequencing of highly pure synovial tissue macrophages reveals two distinct osteoarthritis subgroups that indicate different disease mechanisms. 1.46
Nuclear import of the DSCAM-cytoplasmic domain drives signaling capable of inhibiting synapse formation 1.44
Transcriptomic analysis of senescent cells upon EXOC7 knockdown. 1.42
SNHG5 siRNA knock down in HCT116 cells 1.41
SNHG12 knockdown in Human Umbilical Vein Cells under ROS conditions. 1.41
Human Bone Marrow Assessment by Single Cell RNA Sequencing, Mass Cytometry and Flow Cytometry [bulk] 1.39
Wnt1 silences CC/CXC motif chemokine genes in dendritic cells and induces adaptive immune resistance in lung adenocarcinoma 1.39
Molecular characterization of gene regulatory networks in primary human tracheal and bronchial epithelial cells. 1.36
Differential expression of long non‑coding RNA and mRNA in children with Henoch‑Schönlein purpura nephritis 1.35
Non-inflammatory tumor microenvironment of Diffuse Intrinsic Pontine Glioma (DIPG) 1.29
The influence of PPFIA1 silencing to gene expression in breast carcinoma cell line and head and neck squamous cell carcinoma cell lines by RNA-sequencing in three dimensional collagen I 1.29
Identification of grade and origin specific cell populations in serous epithelial ovarian cancer by single cell RNA-seq 1.28
Pluripotent stem cell model of Nakajo-Nishimura syndrome untangles proinflammatory pathways mediated by oxidative stress 1.23
ETS1 induction by the omental microenvironment promotes ovarian cancer metastasis 1.23
ETS1 induction by the omental microenvironment promotes ovarian cancer metastasis [RNA-Seq] 1.23
A Suv39H1-low chromatin state drives migratory cell populations in cervical cancer [RNA-Seq] 1.23
A Suv39H1-low chromatin state drives migratory cell populations in cervical cancer 1.23
Global gene expression profile of dasatinib-resistant RCH-ACV cells 1.2
Exploiting Prmt5-orchestrated intron detention signatures to treat splicing-addicted malignant glioma tumors 1.19
Next generation sequencing of the transcriptome in MCF-7 cells with/without SRA knockdown 1.16
The anti-leukemic effect of R-2HG depends on its acting as an m6A mRNA modifier-RNA Seq-Resistant, sensitive and healthy control 1.15
Transcriptomic insights into human decidual and peripheral blood CD4 T cells 1.11
RNA deep sequencing to compare genome-wide differences between PRMT5/knockdown and control AML cells 1.11
miR-155 plays a crucial role in ALS and is an immune therapeutic target [RNA-Seq] 1.09
Targeting miR-155 restores abnormal microglia and attenuates disease in SOD1 mice 1.09
An interaction with Ewing's sarcoma breakpoint protein EWS defines the specific oncogenic mechanism of ETS factors rearranged in prostate cancer 1.08
Novel SF3B1 Deletion Mutations Result in Aberrant RNA Splicing in CLL Patients 1.08
Innate Immune Landscape in Early Lung Adenocarcinoma by Paired Single-Cell Analyses 1.07
RNA-seq analysis reveals endogenous aryl hydrocarbon receptor regulation is highly associated with eicosanoid synthesis and tumor necrosis factor activity in MCF-7 cancer cells 1.04
Next Generation Sequencing Facilitates Quantitative Analysis of SW480 cells and HPSE-knockdown SW480 cells Transcriptomes 1.02
Protein kinase A-mediated phosphorylation regulates STAT3 activation and oncogenic EZH2 activity 1.01
RNA-seq of CD33 KO and control HSPCs 1.0
Radiation enhances melanoma response to immunotherapeutic and synergizes with benzodiazepines to promote improved anti-tumor activity 0.99
MAIT cell RNA sequencing 0.94
ChIP-seq and RNA-seq analysis of KMT2D-silenced metastatic melanoma cells 0.94
single cell RNA-seq from Purkinje cell (ENCSR888LYA) 0.91
RNA-Seq analysis of human neutrophils isolated by different protocols (Polymorphprep and negative selection) and incubated with and without in vitro cytokine stimulation 0.91
Microenvironmental-derived Regulation of HIF-Signaling Drives Transcriptional Heterogeneity in Glioblastoma Multiforme 0.9
Direct in vivo evidence for B-cell receptor and NF-KB activation in mantle cell lymphoma: role of the lymph node microenvironment and activating mutations. 0.88
Direct in vivo evidence for B-cell receptor and NF-KB activation in mantle cell lymphoma: role of the lymph node microenvironment and activating mutations. [RNA-Seq] 0.88
Alterations of the MEK/ERK, BMP, and Wnt/b-catenin pathways detected in the blood of individuals with lymphatic malformations 0.82
RNAseq transcriptome analysis of White Blood Cells (WBCs) from individuals with and without trisomy 21 [stranded] 0.8
Folate modulation induces chromosomal instability and higher proliferation of immortalized human keratinocytes 0.79
RNA-sequencing study of peripheral blood monocytes for chronic periodontitis 0.78
Tpl-2 small molecule project 0.78
Tpl-2 and MEK small molecule inhibitors 0.78
Vitamin C Promotes Apoptosis in Breast Cancer Cells by Increasing TRAIL Expression 0.77
ZEB1 insufficiency causes corneal endothelial cell state transition and altered cellular processing 0.76
RNA-seq on Enasidenib or DMSO Treated CD71+ Cells from Umbilical Cord Blood (UCB) 0.75
CD8+ T cells regulate tumor ferroptosis during cancer immunotherapy 0.75
ICF-specific DNMT3B dysfunction interferes with intragenic regulation of mRNA transcription and alternative splicing (RNA-seq) 0.74
ICF-specific DNMT3B dysfunction interferes with intragenic regulation of mRNA transcription and alternative splicing 0.74
Transcriptional dependencies in diffuse intrinsic pontine glioma 0.74
The LRF/ZBTB7A transcription factor is a BCL11A-independent repressor of fetal hemoglobin 0.74
mRNA recovered upon RNF219 IP. [RNA-IP] 0.73
RNA-Seq of CD34+ Bone Marrow Progenitors from Healthy Donors 0.67
Functional significance of the HIV-1 Tat signature amino acid residues 0.65
TALEN-based knockout of mir-141 and mir-200c in SK-BR-3 cells 0.63
Function and hormonal regulation of GATA3 in human first trimester placentation 0.63
Time-dependent regulation of cellular programming of monocytes by NCOR2 [RNASeq_TK] 0.63
Investigation about Monocytes in metastatic breast cancer patients under chemotherapy +/- Avastin 0.61
A comprehensive gene expression analysis identifies novel immune signatures in cesarean-born infants 0.57
RNA-seq analysis in Cornea epithelial cells (CECs), skin epithelial cells (SECs), LSCs after knocking down PAX6 (3-D shPAX6 LSCs) and SESCs transduced with PAX6(3-D PAX6+ SESCs) upon 3-D differentiation 0.56
Transcriptional Down-regulation of CCR5 in a Subset of HIV+ Controllers (RNA-Seq) 0.55
Transcriptional Down-regulation of CCR5 in a Subset of HIV+ Controllers 0.55
Transcriptome profiling (RNA-seq) of CREBBP+/+ and CREBBP+/- clones of U2932 DLBCL cell line 0.54
Transcriptome analysis of V336Y mutant mitochondrial ribosomal protein in human HEK293 cell line 0.51
FOXO1 is an oncogenic mediator in AML1-ETO leukemia 0.49
IL-21/type I interferon interplay regulates neutrophil-dependent innate immune responses to Staphylococcus aureus 0.45
Transcriptome of Primitive Human Hematopoietic Cells: A New Resource to Find hHSC-Specific Genes 0.44
Direct interaction of MYCN and p53 regulate transcriptional responses in neuroblastoma 0.4
Direct interaction of MYCN and p53 regulate transcriptional responses in neuroblastoma [RNA-Seq] 0.4
TT-seq captures simultaneous activation of eRNAs and promoters during T cell activation 0.36
Expression of the mannose receptor (CD206) defines distinct populations of human colonic macrophages in health and inflammatory bowel disease 0.34
Nickel exposure induces persistent mesenchymal phenotype in human lung epithelial cells through epigenetic activation of ZEB1 0.3
The Regulation of IFN Type I Pathway Related Genes RSAD2 and ETV7 Specifically Indicate Antibody-Mediated Rejection After Kidney Transplantation 0.3
The RNA-binding protein RBM47 suppresses metastatic breast cancer progression 0.28
Transcriptomics profiling of CD141+ dendritic cells isolated from peripheral blood or synovial fluid of arthritis patients 0.28
IL-10 dysregulation in acute mountain sickness revealed by transcriptome analysis 0.25
A novel tumor-associated myeloid cell population inhibits antigen-specific immune responses in cancer patients 0.23
Bromodomain protein BRD4 is a transcriptional repressor of autophagy and lysosomal function 0.23
Polarized B -cell functions 0.23
Effect of nuclear IL-33 on gene expression 0.23
The secretome of skin cancer cells activates the mTOR/MYC pathway in healthy keratinocytes and converts them into tumorigenic cells 0.22
Gene expression changes due to PARP knockdown in human cells 0.17
Transcriptional profiling of SF295 cells following MTF1 knockout by CRISPR/Cas9 0.15
Longitudinal transcriptome profiling of post-treatment Lyme disease syndrome 0.12
Single cell transcriptomics analysis of induced pluripotent stem cell-derived cortical neurons reveals frequent dual layer identity 0.12
RNA-seq of primary patient AML samples 0.11
A novel Menin-MLL inhibitor induces specific chromatin changes and eradicates disease in models of MLL-rearranged leukemia [RNA-Seq II] 0.11
Integrated analysis of MLL-AF9 AML patients and model leukemias highlights RET and other novel therapeutic targets (RNA-seq AML development) 0.11
CT Irradiation Induced Changes of Gene Expression within Peripheral Blood Cells 0.1
RNA-seq of HUVEC ± shRNA knockdown of SENCR 0.1
Transcriptomic analysis of the effect of histone H4 K31R mutation in U2OS cells 0.08
SAMHD1 is recurrently mutated in T-cell prolymphocytic leukemia [RNA-seq] 0.08
Identification of a unique gene expression signature in mercury and 2,3,7,8-tetrachlorodibenzo-p-dioxin co-exposed cells 0.07
The Small Molecule ISRIB Reverses the Effects of eIF2α Phosphorylation on Translation and Stress Granule Assembly 0.05
Expression changes in MAPKi resistant M229 melanoma lines co-cultured with PD-1 overexpressing HEK293T cells [CellLine.FPKM.batch5] 0.04
Peripheral whole blood mRNAs and lncRNAs expression analysis in eosinophilic asthmatics 0.03


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation